EVE Stock Overview
Eve Health Group Limited, together with its subsidiaries, engages in the production and marketing of nutrition, health, and wellness products in Australia, North America, China, and Asia.
Eve Health Group Peers
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.001|
|52 Week High||AU$0.006|
|52 Week Low||AU$0.001|
|1 Month Change||-50.00%|
|3 Month Change||-75.00%|
|1 Year Change||-83.33%|
|3 Year Change||-80.00%|
|5 Year Change||-85.71%|
|Change since IPO||-96.67%|
Recent News & Updates
|EVE||AU Food||AU Market|
Return vs Industry: EVE underperformed the Australian Food industry which returned -6.1% over the past year.
Return vs Market: EVE underperformed the Australian Market which returned 2.1% over the past year.
|EVE Average Weekly Movement||55.2%|
|Food Industry Average Movement||6.0%|
|Market Average Movement||9.5%|
|10% most volatile stocks in AU Market||16.7%|
|10% least volatile stocks in AU Market||4.3%|
Stable Share Price: EVE is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 55% a week.
Volatility Over Time: EVE's weekly volatility has increased from 32% to 55% over the past year.
About the Company
Eve Health Group Limited, together with its subsidiaries, engages in the production and marketing of nutrition, health, and wellness products in Australia, North America, China, and Asia. The company operates through three segments: Jenbrook, Meluka, and Investment. It provides organic tea tree oils and essential oils; and distributes botanical oils.
Eve Health Group Fundamentals Summary
|EVE fundamental statistics|
Is EVE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EVE income statement (TTM)|
|Cost of Revenue||AU$1.19m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.0013|
|Net Profit Margin||-237.50%|
How did EVE perform over the long term?See historical performance and comparison
How is Eve Health Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eve Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Eve Health Group performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EVE is currently unprofitable.
Growing Profit Margin: EVE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EVE is unprofitable, and losses have increased over the past 5 years at a rate of 22.5% per year.
Accelerating Growth: Unable to compare EVE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EVE is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (5.1%).
Return on Equity
High ROE: EVE has a negative Return on Equity (-77.18%), as it is currently unprofitable.
How is Eve Health Group's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: EVE's short term assets (A$2.5M) exceed its short term liabilities (A$771.0K).
Long Term Liabilities: EVE's short term assets (A$2.5M) exceed its long term liabilities (A$773.1K).
Debt to Equity History and Analysis
Debt Level: EVE has more cash than its total debt.
Reducing Debt: Insufficient data to determine if EVE's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EVE has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: EVE is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.
What is Eve Health Group current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EVE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EVE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EVE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EVE's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as EVE has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Bill Fry (55 yo)
Mr. Gregory William Fry, also known as Bill, serves as Managing Director and Chief Executive Officer at Eve Health Group Limited (formerly known as EVE Investments Limited) (formerly known as Energy Ventur...
CEO Compensation Analysis
Compensation vs Market: Bill's total compensation ($USD280.54K) is about average for companies of similar size in the Australian market ($USD285.05K).
Compensation vs Earnings: Bill's compensation has increased whilst the company is unprofitable.
Experienced Management: EVE's management team is considered experienced (3.2 years average tenure).
Experienced Board: EVE's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.1%.
Eve Health Group Limited's employee growth, exchange listings and data sources
- Name: Eve Health Group Limited
- Ticker: EVE
- Exchange: ASX
- Founded: 2003
- Industry: Packaged Foods and Meats
- Sector: Food, Beverage & Tobacco
- Implied Market Cap: AU$4.310m
- Shares outstanding: 4.31b
- Website: https://www.evehealthgroup.com.au
- Eve Health Group Limited
- 245 Churchill Avenue
- Suite 1
- Western Australia
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/19 00:00|
|End of Day Share Price||2022/05/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.